Pentixapharm Holding AG

Director's Dealing • Nov 27, 2025

News Details

Directors’ Dealings | 27 November 2025 10:29

Pentixapharm Holding AG: Eckert Wagniskapital und Frühphasenfinanzierung GmbH, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

27.11.2025 / 10:28 CET/CEST

The issuer is solely responsible for the content of this announcement.

---

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Name and legal form:	Eckert Wagniskapital und Frühphasenfinanzierung GmbH

2. Reason for the notification

a) Position / status

Person closely associated with:
Title:	Dr.
First name:	Andreas
Last name(s):	Eckert
Position:	Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Pentixapharm Holding AG

b) LEI

3912005VBOVXNDXEQZ36

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A40AEG0

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s)	Volume(s)
1.40 EUR	99,293.50 EUR

d) Aggregated information

Price	Aggregated volume
1.40 EUR	99,293.50 EUR

e) Date of the transaction

26/11/2025; UTC+1

f) Place of the transaction

Outside a trading venue

---

27.11.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

View original content: EQS News

---

Language:	English
Company:	Pentixapharm Holding AG
	Robert-Rössle-Straße 10
	13125 Berlin
	Germany
Internet:	https://www.pentixapharm.com/

End of News	EQS News Service

---

102074  27.11.2025 CET/CEST